Effect of Advanced Glycation End Products on Human Thyroglobulin's Antigenicity as Identified by the Use of Sera from Patients with Hashimoto's Thyroiditis and Gestational Diabetes Mellitus

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Hatzioannou, A ^a   Kanistras, I ^a   Mantzou, E ^b   Anastasiou, E ^c   Peppa, M ^d   Sarantopoulou, V ^c   Lymberi, P ^a   Alevizaki, M ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE 6 PHOSPHATE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; THYROGLOBULIN;

ANTIGENICITY; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CLINICAL PRACTICE; CONTROLLED STUDY; COVALENT BOND; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HASHIMOTO DISEASE; HUMAN; IMMUNOGENICITY; INCUBATION TIME; MAJOR CLINICAL STUDY; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 84937020249     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/849615     Document Type: Article

References (30)

1. A. G.Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E. B. Reusch, "Diabetes and advanced glycoxidation end products, " Diabetes Care, vol. 29, no. 6, pp. 1420-1432, 2006.
2. W. G. John, "Glycated haemoglobin analysis, " Annals of Clinical Biochemistry, vol. 34, part 1, pp. 17-31, 1997.
3. R. J. Koenig, C. M. Peterson, R. L. Jones, C. Saudek, M. Lehrman, and A. Cerami, "Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus, " The New England Journal of Medicine, vol. 295, no. 8, pp. 417-420, 1976.
4. H. F. Bunn, K. H. Gabbay, and P. M. Gallop, "The glycosylation of hemoglobin: relevance to diabetesmellitus, " Science, vol. 200, no. 4337, pp. 21-27, 1978.
5. V. Jakuš, E.Šándorová, J. Kalninová, and B. Krahulec, "Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus, " Physiological Research, vol. 63, no. 3, pp. 297-309, 2014.
6. M. Preciado-Puga, J. M. Malacara, M. E. Fajardo-Araujo et al., "Markers of the progression of complications in patients with type 2 diabetes: a One-Year Longitudinal Study, " Experimental and Clinical Endocrinology&Diabetes, vol. 122, no. 08, pp. 484-490, 2014.
7. Z. Turk, S. Ljubic, N. Turk, and B. Benko, "Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus, " Clinica Chimica Acta, vol. 303, no. 1-2, pp. 105-115, 2001.
8. M. M. Newkirk, R. Goldbach-Mansky, J. Lee et al., "Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis, " Arthritis Research &Therapy, vol. 5, no. 2, pp. R82-R90, 2003.
9. C. V. Prowse and I. R.MacGregor, "Neoantigens and antibodies to factor VIII, " Blood Reviews, vol. 12, no. 2, pp. 99-105, 1998.
10. S. Reddy, J. Bichler, K. J. Wells-Knecht, S. R. Thorpe, and J. W. Baynes, "Nε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins, " Biochemistry, vol. 34, no. 34, pp. 10872-10878, 1995.
11. K. Ikeda, T. Higashi, H. Sano et al., "N (epsilon)-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction, " Biochemistry, vol. 35, no. 24, pp. 8075-8083, 1996.
12. G. Virella, S. R. Thorpe, N. L. Alderson et al., "Autoimmune response to advanced glycosylation end-products of human LDL, " Journal of Lipid Research, vol. 44, no. 3, pp. 487-493, 2003.
13. H. F. Cheng, R. E. Peterson, and T. C. Evans, "Preparation of highly purified human thyroglobulin, " Biochimica et Biophysica Acta, vol. 168, no. 1, pp. 161-164, 1968.
14. U. K. Laemmli, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4, " Nature, vol. 227, no. 5259, pp. 680-685, 1970.
15. Z. Makita, H. Vlassara, A. Cerami, and R. Bucala, "Immunochemical detection of advanced glycosylation end products in vivo, " The Journal of Biological Chemistry, vol. 267, no. 8, pp. 5133-5138, 1992.
16. T. Mitsuhashi, H. Vlassara, H. W. Founds, and Y. M. Li, "Standardizing the immunological measurement of advanced glycation endproducts using normal human serum, " Journal of Immunological Methods, vol. 207, no. 1, pp. 79-88, 1997.
17. D. G. Mappouras, G. Philippou, S. Haralambous, S. J. Tzartos, A. Balafas, and P. Lymberi, "Antibodies to acetylcholinesterase cross-reacting with thyroglobulin in myasthenia gravis and Graves' disease, " Clinical and Experimental Immunology, vol. 100, no. 2, pp. 336-343, 1995.
18. A. Thrasyvoulides and P. Lymberi, "Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide, " Clinical&Experimental Immunology, vol. 132, no. 3, pp. 401-407, 2003.
19. Z. Turk, R. Mesić, and B. Benko, "Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control, " Clinica Chimica Acta, vol. 277, no. 2, pp. 159-170, 1998.
20. Y. Kiso, J. Furmaniak, C. Morteo, and B. R. Smith, "Analysis of carbohydrate residues on human thyroid peroxidase (tpo) and thyroglobulin (tg) and effects of deglycosylation, reduction and unfolding on autoantibody binding, " Autoimmunity, vol. 12, no. 4, pp. 259-269, 1992.
21. R. E. Perry, M. S. Swamy, and E. C. Abraham, "Progressive changes in lens crystallin glycation and high-molecularweight aggregate formation leading to cataract development in streptozotocin-diabetic rats, " Experimental Eye Research, vol. 44, no. 2, pp. 269-282, 1987.
22. Y. H. A. Abdel-Wahab, F. P. M. O'Harte, H. Ratcliff, N. H. McClenaghan, C. R. Barnett, and P. R. Flatt, "Glycation of insulin in the islets of Langerhans of normal and diabetic animals, " Diabetes, vol. 45, no. 11, pp. 1489-1496, 1996.
23. H.-M. Raabe, J.-H. Höpner, H. Notbohm, G. H. G. Sinnecker, K. Kruse, and P. K. Müller, "Biochemical and biophysical alterations of the 7S and NC1 domain of collagen IV from human diabetic kidneys, " Diabetologia, vol. 41, no. 9, pp. 1073-1079, 1998.
24. K. Sugimoto, Y. Nishizawa, S. Horiuchi, and S. Yagihashi, "Localization in human diabetic peripheral nerve of Nε-carboxymethyllysine-protein adducts, an advanced glycation endproduct, " Diabetologia, vol. 40, no. 12, pp. 1380-1387, 1997.
25. E. L. Jacobson, D. Cervantes-Laurean, and M. K. Jacobson, "ADP-ribose in glycation and glycoxidation reactions, " Advances in Experimental Medicine and Biology, vol. 419, pp. 371-379, 1997.
26. R.Bucala, R.Mitchell, K.Arnold, T. Innerarity, H.Vlassara, and A. Cerami, "Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor, " The Journal of Biological Chemistry, vol. 270, no. 18, pp. 10828-10832, 1995.
27. C. Duthoit, V. Estienne, A. Giraud et al., "Hydrogen peroxideinduced production of a 40 kda immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity?" Biochemical Journal, vol. 360, no. 3, pp. 557-562, 2001.
28. A. Lapolla, P. Traldi, and D. Fedele, "Importance of measuring products of non-enzymatic glycation of proteins, " Clinical Biochemistry, vol. 38, no. 2, pp. 103-115, 2005.
29. B. Buttari, E. Profumo, A. Capozzi et al., "Advanced glycation end products of human β2 glycoprotein Imodulate the maturation and function of DCs, " Blood, vol. 117, no. 23, pp. 6152-6161, 2011.
30. G. Napolitano, I. Bucci, C. Giuliani et al., "High glucose levels increase major histocompatibility complex class I gene expression in thyroid cells and amplify interferon-γ action, " Endocrinology, vol. 143, no. 3, pp. 1008-1017, 2002.